Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products, Inc. (Nasdaq: UTMD) has announced a quarterly cash dividend of $0.30 per share of common stock. This represents a 1.7% increase compared to the dividend declared in the same quarter of the previous year. The dividend will be payable on October 4, 2024, to stockholders of record at the close of business on September 20, 2024.
UTMD specializes in developing, manufacturing, and marketing a wide range of disposable and reusable specialty medical devices, with a particular focus on healthcare for women and their babies. The company's products are recognized by clinicians in over 100 countries worldwide as the standard for achieving optimal long-term patient outcomes.
Utah Medical Products, Inc. (Nasdaq: UTMD) ha annunciato un dividendo in contanti trimestrale di $0,30 per azione di azioni ordinarie. Questo rappresenta un aumento del 1,7% rispetto al dividendo dichiarato nello stesso trimestre dell'anno precedente. Il dividendo sarà pagabile il 4 ottobre 2024, agli azionisti registrati alla chiusura degli affari del 20 settembre 2024.
UTMD si specializza nello sviluppo, nella produzione e nel marketing di una vasta gamma di dispositivi medici specializzati usa e getta e riutilizzabili, con un particolare focus sulla salute delle donne e dei loro neonati. I prodotti dell'azienda sono riconosciuti dai clinici in oltre 100 paesi in tutto il mondo come standard per ottenere risultati ottimali a lungo termine per i pazienti.
Utah Medical Products, Inc. (Nasdaq: UTMD) ha anunciado un dividendo en efectivo trimestral de $0.30 por acción de acciones comunes. Esto representa un aumento del 1.7% en comparación con el dividendo declarado en el mismo trimestre del año anterior. El dividendo se pagará el 4 de octubre de 2024, a los accionistas registrados al cierre de operaciones del 20 de septiembre de 2024.
UTMD se especializa en el desarrollo, la fabricación y la comercialización de una amplia gama de dispositivos médicos especializados desechables y reutilizables, con un enfoque particular en la atención médica para mujeres y sus bebés. Los productos de la empresa son reconocidos por clínicos en más de 100 países de todo el mundo como el estándar para lograr resultados óptimos a largo plazo para los pacientes.
유타 메디컬 프로덕츠, Inc. (Nasdaq: UTMD)가 보통주 1주당 $0.30의 분기 현금 배당금을 발표했습니다. 이는 지난해 같은 분기에 발표된 배당금에 비해 1.7% 증가한 수치입니다. 배당금은 2024년 10월 4일에 지급되며, 2024년 9월 20일 업무 종료 시점에 주주로 등재된 이들에게 지급됩니다.
UTMD는 일회용 및 재사용 가능한 전문 의료 기기를 개발, 제조 및 마케팅하는 데 특화되어 있으며, 여성과 아기들을 위한 건강 관리에 특히 중점을 두고 있습니다. 이 회사의 제품은 전 세계 100개국 이상의 임상의들에 의해 최적의 장기 환자 결과를 달성하기 위한 기준으로 인정받고 있습니다.
Utah Medical Products, Inc. (Nasdaq: UTMD) a annoncé un dividende en espèces trimestriel de 0,30 $ par action ordinaire. Cela représente une augmentation de 1,7% par rapport au dividende déclaré au même trimestre de l'année précédente. Le dividende sera payable le 4 octobre 2024, aux actionnaires inscrits à la clôture des affaires le 20 septembre 2024.
UTMD se spécialise dans le développement, la fabrication et la commercialisation d'une large gamme de dispositifs médicaux spécialisés à usage unique et réutilisables, avec un accent particulier sur la santé des femmes et de leurs bébés. Les produits de l'entreprise sont reconnus par des cliniciens dans plus de 100 pays à travers le monde comme étant la norme pour obtenir des résultats optimaux à long terme pour les patients.
Utah Medical Products, Inc. (Nasdaq: UTMD) hat eine vierteljährliche Barausschüttung von $0,30 pro Aktie der Stammaktien angekündigt. Dies stellt eine 1,7%ige Erhöhung im Vergleich zur im selben Quartal des Vorjahres erklärten Dividende dar. Die Dividende wird am 4. Oktober 2024 an die Aktionäre ausgezahlt, die zum Ende des Geschäftstags am 20. September 2024 im Unternehmensregister stehen.
UTMD ist auf die Entwicklung, Herstellung und Vermarktung einer breiten Palette von Einweg- und wiederverwendbaren spezialisierten medizinischen Geräten spezialisiert, mit einem besonderen Fokus auf die Gesundheitsversorgung für Frauen und deren Babys. Die Produkte des Unternehmens sind von Klinikern in über 100 Ländern weltweit als Standard für optimale langfristige Patientenresultate anerkannt.
- Quarterly dividend increased by 1.7% year-over-year
- Company maintains consistent dividend payments, indicating financial stability
- UTMD's products are recognized as standard in over 100 countries
- None.
SALT LAKE CITY, UT / ACCESSWIRE / August 2, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share of common stock payable on October 4, 2024 to stockholders of record at the close of business on September 20, 2024. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on accesswire.com
FAQ
What is the new quarterly dividend amount for Utah Medical Products (UTMD)?
When is the payment date for UTMD's latest dividend?
What is the record date for UTMD's Q3 2024 dividend?
How much has UTMD increased its dividend compared to the previous year?
What is Utah Medical Products' (UTMD) primary business focus?
